Meaghan Boileau
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors
Most-Cited Works
- → Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity(2015)164 cited
- → Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia(2018)92 cited
- → Complement cascade gene expression defines novel prognostic subgroups of acute myeloid leukemia(2016)48 cited
- → Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness(2019)47 cited
- → Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy(2022)46 cited
- → Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation(2019)45 cited
- → An Evolutionary Model Encompassing Substrate Specificity and Reactivity of Type I Polyketide Synthase Thioesterases(2014)33 cited
- → Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML(2023)25 cited
- → CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2 - and TET2 -mutant Cells(2024)8 cited
- → An in vivo barcoded CRISPR-Cas9 screen identifies Ncoa4-mediated ferritinophagy as a dependence in Tet2-deficient hematopoiesis(2025)7 cited